Quick Answer
AGIOS PHARMACEUTICALS, INC. reported Shares Outstanding of 58.45 million shares for fiscal year 2025.
AGIOS PHARMACEUTICALS, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 58.45M | +2.3% |
| 2024 | 57.16M | +2.2% |
| 2023 | 55.95M | +1.6% |
| 2022 | 55.04M | +1.3% |
| 2021 | 54.33M | -21.6% |
| 2020 | 69.29M | +1.3% |
| 2019 | 68.40M | +17.5% |
| 2018 | 58.22M | +19.2% |
| 2017 | 48.83M | +15.6% |
| 2016 | 42.22M | +12.0% |
| 2015 | 37.70M | +1.6% |
| 2014 | 37.10M | +18.9% |
| 2013 | 31.20M | +762.9% |
| 2012 | 3.62M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 58.28M | +2.2% | +0.4% |
| June 30, 2025 | 58.04M | +2.0% | +0.3% |
| March 31, 2025 | 57.89M | +2.0% | +1.3% |
| December 31, 2024 | 57.16M | +2.2% | +0.2% |
| September 30, 2024 | 57.02M | +2.0% | +0.3% |
| June 30, 2024 | 56.88M | +2.0% | +0.2% |
| March 31, 2024 | 56.75M | +2.2% | +1.4% |
| December 31, 2023 | 55.95M | +1.6% | +0.1% |
- AGIOS PHARMACEUTICALS, INC. showed an increase of +2.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2012–2025 period, AGIOS PHARMACEUTICALS, INC.’s shares outstanding has grown by 1516.3% (from 3.62 million shares to 58.45 million shares).
- The most recent figure is from AGIOS PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: